Auriga Laboratories, Inc. Announces the Launch of Extendryl®(R) PEM and Extendryl(R) GCP
CAMARILLO, CA--(Marketwire - March 20, 2008) - Auriga Laboratories, Inc. (OTCBB: ARGA), a specialty pharmaceutical company, announced today the launch of Extendryl® PEM and Extendryl® GCP. The two new products will be marketed under the Extendryl brand name which consists of prescription products to treat various cough, cold, and allergy symptoms.